The first flu vaccine developed by using the cell-culturing method in Korea. It can provide a large amount of vaccine in a short period of time, as this method can produce a large amount of specific cells which are necessary for cultivating viruses in advance. Furthermore, people with egg allergies can be inoculated at the same time.

The world’s first WHO PQ-certified Quadrivalent flu vaccine developed by next-generation technology. Cell culture-derived method reduces the possibility of mutations that can occur in the incubation process, and has a high preventive effect.

Prefilled syringe-typed shingles vaccine that increases convenience and stability. It is manufactured in a way that is gaining global attention due to its high convenience, accurate dosage, and prevention of contamination when preparing for injection.

The world’s second WHO PQ-certified chickenpox virus vaccine, it was developed in Korea through a process of cell culture, virus infection, and refinement using the latest sterile production system.